Respiratory syncytial virus (RSV) is an important cause of acute respiratory infections (ARIs) in children; about 60% of children get infected with RSV by the 1 st year and 100% by the 2 nd year of life. [1] As per the World Health Organization, RSV is responsible for 4 million deaths around the world annually in children <5 years of age. [2] The virus is mostly seen in children with bronchiolitis and pneumonia. [3] Repeated infections and yearly outbreaks of RSV possibly occur due to the antigenic variability of the virus which is a challenge for designing and development of vaccine. [3] To optimise the prophylaxis, it is important to forecast the trends of RSV infection in a given area for better prevention and control.
Real-time reverse transcription polymerase chain reaction
Initial screening for the presence of RSV was done using previously published primer probes for RSV by real-time reverse transcription polymerase chain reaction amplification [4] (synthesised by Applied Biosystems Inc., USA). Samples positive for RSV were retested separately for RSV A and RSV B on ABI 7500 fast (Applied Biosystems Inc., USA). The primer probe for sub-typing of RSV A and RSV B was synthesised (TIB MOL, from TIB MOLBIOL, Berlin, Germany) as per the published literature. [5] 
Results
Six hundred and eighty-nine samples from hospitalised children of age ≤ 5 years were screened for possible RSV infection. The total positivity for RSV was found to be 175/689 (25.40%), 133/490 (27.14%) in males and 42/199 (21.10%) in females. RSV B was found positive in 20.03% (138/689) patients, RSV A in 2.90% (20/689) patients and RSV AB in 2.47% (17/689) patients. Correlation of RSV sub-types in relation to signs, symptoms and clinical syndromes is mentioned in Table 1 .
Age-wise distribution of Respiratory syncytial virus A, Respiratory syncytial virus B and Respiratory syncytial virus AB
The occurrence of RSV infections varied in different age groups. Maximum positivity was observed in age group 1-12 months (36.13%), which was statistically significant (P < 0.001) (Chi-square test), followed by 13-24 months age group (18.34%); very low positivity was found in other age groups (2.33%-8.82%).
Seasonal distribution of Respiratory syncytial virus A, Respiratory syncytial virus B and Respiratory syncytial virus AB
In the 1 st year of the study from September 2012 to August 2013, the only circulating type of RSV was the RSV A with its peak in March 2013, at the end of winter season. In the 2 nd year of study from September 2013 to August 2014, both the types and mixed infections, i.e., RSV A, RSV B and RSV AB, were found to be circulating. All the RSV types were found to be circulating mainly during winter months and post-monsoon season [ Figure 1 ].
discussion
RSV is an important cause of mortality and morbidity requiring hospitalisation in the first few years of life. The present study was first to report the trends of RSV A and RSV B from Jaipur and Rajasthan in the hospitalised children ≤5 years of age. During the study period of 27 months, total positivity of RSV was found to be 25.40%. This is in correlation with an earlier study which reported a positivity of 26%. [6] On RSV typing of positive samples in the present study, predominance of RSV B (78.85%) was observed as compared to RSV A and RSV AB mixed infections. This is consistent with an earlier Indian study from Delhi (64.44%) [7] and other studies globally, from Malaysia (73.36%), [8] Zagreb (83.60%) [9] and Brazil (92.07%). [6] A study from Kolkata (India) reported predominance of RSV B (95%) in the 1 st year, which was replaced by RSV A (94.84%) in the consequent years of the study. [10] In the present study, RSV was positive predominantly (36.13%) in the hospitalised children <12 months of age. RSV is known to be an important cause of hospitalisation in children younger than 1 year of age. [6] This may be due to low levels of immunity in infants. In the present study, pneumonia was observed in 51.42% and bronchiolitis in 12.57% of RSV-positive patients. Earlier studies reported bronchiolitis in 47.1% to 82% [1, 11] and pneumonia in 36.2%-76% [1, 11] in RSV-positive patients. RSV B was the predominant RSV type detected in the present study in the hospitalised children of ≤5 years of age. RSV B was reported to be a more common cause of bronchiolitis and pneumonia than sub-type A. [9] During the 1 st year of our study, only RSV A was the type of RSV circulating whereas, during the 2 nd and 3 rd year of the study, all the two types and mixed infections, i.e., RSV A, RSV B and RSV AB, were found to be co circulating. The exact reason for this variation in the circulation patterns of RSV during different years of the study is not known. Similarly co-circulation of RSV A and RSV B has been found in other studies from India and Germany with the predominance of RSV A sub-group. [12, 13] conclusion RSV B was the most predominant type circulating in our area with co-circulation of RSV A and RSVAB. Peak positivity was seen in winters and lower positivity in post-monsoon season. Palivizumab can be planned to be given post-monsoon till winters are over. Only hospitalised patients were studied in present study which is a limitation but provides information on trends in serious patients and can provide guidance to plan prevention and control policies.
